Today: 21 April 2026
Gold Price Rebounds, but Iran War Still Leaves Bullion Facing Its Worst Month Since 2008 (Reuters)
31 March 2026
2 mins read

Gold Price Rebounds, but Iran War Still Leaves Bullion Facing Its Worst Month Since 2008 (Reuters)

NEW YORK, March 31, 2026, 10:11 a.m. EDT

Gold picked up in early New York trading Tuesday, though bullion remained headed for its sharpest monthly decline since October 2008. Spot gold—the immediate-delivery price—stood at $4,572.89 an ounce by 8:50 a.m. EDT, having earlier climbed to its highest mark since March 20.

Gold is supposed to be the classic refuge when worries about both war and inflation rise. But that’s not what we’ve seen this month. Oil has jumped on the Iran conflict, inflation expectations have ticked up, and traders are dialing back bets on rate cuts—a tough backdrop for gold, which doesn’t offer any yield.

Gold traded at $4,578 an ounce as of 9 a.m. ET, according to a daily Fortune tracker—an $11 gain since Monday, yet the metal remains 12.4% under its level one month ago. The recent uptick hasn’t been enough to deliver the protection buyers were counting on during a geopolitical shock.

Energy is taking the hit. Brent crude climbed 2.4%, reaching $115.50 a barrel Tuesday. Analysts surveyed by Reuters have bumped their 2026 Brent outlook up by 30%. The trigger: the war has closed the Strait of Hormuz, a chokepoint handling roughly 20% of global oil and LNG shipments.

Peter Grant, vice president and senior metals strategist at Zaner Metals, described the rally as “encouraging,” but said he’s holding out for more upside before calling it a real shift. He cautioned that any factor raising the chances of a Federal Reserve rate hike could drag prices down, despite ongoing de-dollarization and steady central-bank buying supporting the longer-term picture. BMI left its 2026 gold forecast unchanged at $4,600 on average, while Goldman Sachs still sees bullion hitting $5,400 by year-end 2026. Reuters

Jim Wyckoff at Kitco Metals isn’t seeing any letup in the conflict, noting traders have their eyes just as much on crude prices, bond yields, and the dollar as on battlefield headlines. Over at City Index and FOREX.com, Fawad Razaqzada points to $4,700 through $4,750 as the key patch for gold’s next possible bounce.

The recent selloff has dragged gold back into an uncomfortable spotlight. According to The Economist, gold prices have slid roughly 15% since the conflict erupted on Feb. 28, pressured by higher inflation-adjusted bond yields, central banks offloading reserves, and speculators pulling money from gold-backed funds. Turkey offloaded $8 billion worth of gold in just two weeks through March 20. ETF holdings, which had surged 25% over the year to around 4,200 tonnes, have begun to shrink as investors pull back.

It’s not just gold feeling the pinch. Silver picked up 4.1% to $72.82 on Tuesday—still staring at a 22.4% slump for March. Platinum and palladium also climbed for the session but look on track for losses this month. BNP Paribas expects silver to hold within a $65 to $75 band through 2026.

But that rebound isn’t a sure thing. Ole Hansen at Saxo Bank cautioned that if disruptions drag on for just a few more weeks, crude could edge into “demand destruction territory”—inflation stays hot, rates don’t budge. Flip it around: any real sign of a truce in the conflict might sap some of the safe-haven flows that have helped gold hold steady this week. Reuters

Stock Market Today

  • John Oliver's Last Week Tonight critiques prediction markets like Kalshi and Polymarket
    April 20, 2026, 9:20 PM EDT. John Oliver's Last Week Tonight scrutinizes prediction markets, platforms like Kalshi and Polymarket where users wager on politics, weather, and more, likening them to a betting version of commodities futures. These markets, linked to major news outlets for legitimacy, generate billions by facilitating bets where insiders with advance knowledge profit at the expense of ordinary users. With over two million users primarily losing money and a few accounts capturing most gains, the segment highlights concerns over regulatory gaps, conflicts of interest, and potential corruption. The businesses earn by taking a cut of all wagers, underscoring risks for uninformed bettors. Oliver's critique sheds light on the growing, controversial market entwined with political figures and limited oversight.

Latest article

XRP Price Rally Just Hit a Wall—Why $1.46 Now Matters

XRP Price Rally Just Hit a Wall—Why $1.46 Now Matters

20 April 2026
XRP traded near $1.43 on Monday, down from a Friday high above $1.50. XRP-linked ETFs saw $55.39 million in net inflows last week, their strongest showing of 2026. Market value stood near $88 billion, with traders watching $1.41 as support and $1.46-$1.50 as resistance. XRP outperformed bitcoin and ether last week but slipped as crypto markets pulled back.
Gold Price Today: Why Bullion Fell Even as U.S.-Iran Tensions Flared Again

Gold Price Today: Why Bullion Fell Even as U.S.-Iran Tensions Flared Again

20 April 2026
Spain said it will join an EU plan to share jet fuel stocks and supports joint purchasing as Europe faces shortages after Gulf supply disruptions. Jet fuel prices remain near $175 a barrel and inventories at the Amsterdam-Rotterdam-Antwerp hub hit a four-year low. Airlines including KLM have begun canceling flights due to rising fuel costs. The European Commission is preparing guidance to reduce reliance on Middle Eastern fuel.
Alphabet Stock Slips as Google-Marvell AI Chip Talks Put Spending, Earnings in Focus

Alphabet Stock Slips as Google-Marvell AI Chip Talks Put Spending, Earnings in Focus

20 April 2026
Alphabet shares fell 0.9% to $338.45 Monday after reports Google is in talks with Marvell Technology to develop two AI chips, despite ongoing investor concerns over a projected $175–$185 billion 2026 spending bill. Marvell stock rose 6.1% while Broadcom dropped 2.4%. Alphabet reports first-quarter results April 29. Google and Marvell declined to comment.
Rocket Lab Stock Jumps as Germany Clears Mynaric Buyout, Putting Europe Push in Reach
Previous Story

Rocket Lab Stock Jumps as Germany Clears Mynaric Buyout, Putting Europe Push in Reach

Apellis Pharmaceuticals Jumps as Biogen Agrees $5.6 Billion Buyout
Next Story

Apellis Pharmaceuticals Jumps as Biogen Agrees $5.6 Billion Buyout

Go toTop